Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study

Abstract

Objective In the era of group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis (IAP), GBS colonization has been associated with a lower risk of chorioamnionitis, possibly due to a protective effect of IAP. We sought to confirm this finding and assess whether this association varies by gestational week at delivery.

Study Design We performed a retrospective cohort study of term (37.0–42.6 weeks), singleton parturients with known GBS status who delivered from 2005 to 2021 at two academic medical centers in Israel. We excluded patients who underwent planned cesarean, out of hospital birth, or had a fetal demise. Patients received GBS screening and IAP for GBS positivity as routine clinical care. The primary outcome was a diagnosis of clinical chorioamnionitis as determined by the International Classification of Diseases 10th Revision code, compared between GBS-positive and -negative groups, and assessed by gestational week at delivery.

Results Of 292,126 deliveries, 155,255 met inclusion criteria. In total, 30.1% were GBS positive and 69.9% were negative. GBS-positive patients were 21% less likely to be diagnosed with clinical chorioamnionitis than GBS-negative patients, even after controlling for confounders (1.5 vs. 2.2%, adjusted odds ratio: 0.79, 95% confidence interval: 0.68–0.92). When assessed by gestational week at delivery, there was a significantly greater difference in rates of clinical chorioamnionitis between GBS-positive versus GBS-negative groups with advancing gestational age: 1.5-fold difference at 38 to 40 weeks, but a twofold difference at 42 weeks. The risk of clinical chorioamnionitis remained stable in the GBS-positive group, but increased significantly in the GBS-negative group at 41- and 42-week gestation (2.0 vs. 2.9%, p < 0.01 at 41 weeks; up to 3.9% at 42 weeks, p < 0.01).

Conclusion In a large multicenter cohort with universal GBS screening and IAP, GBS positivity was associated with a lower risk of chorioamnionitis, driven by an increasing rate of chorioamnionitis among GBS-negative patients after 40 weeks.

Key Points

• GBS positivity and IAP may be associated with lower risk of chorioamnionitis.

• GBS-positive patients were less likely to be diagnosed with chorioamnionitis.

• This difference increased with advancing gestational age after 40 weeks.

Keywords

group B Streptococcus - GBS - chorioamnionitis - pathogenic bacterium - antibiotics

Publication History

Received: 15 March 2024

Accepted: 27 May 2024

Accepted Manuscript online:
28 May 2024

Article published online:
21 June 2024

• References

• 1 Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis 1999; 179 (06) 1410-1415
• 2 Minkoff HL, Sierra MF, Pringle GF, Schwarz RH. Vaginal colonization with group B beta-hemolytic Streptococcus as a risk factor for post-cesarean section febrile morbidity. Am J Obstet Gynecol 1982; 142 (08) 992-995
• 3 Muller AE, Oostvogel PM, Steegers EA, Dörr PJ. Morbidity related to maternal group B streptococcal infections. Acta Obstet Gynecol Scand 2006; 85 (09) 1027-1037
• 4 Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol 1996; 87 (02) 188-194
• 5 Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996; 45 (RR-7): 1-24
• 6 Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
• 7 Committee Opinion No. 712: intrapartum management of intraamniotic infection. Obstet Gynecol 2017; 130 (02) e95-e101
• 8 McCoy JA, Bromwich K, Gerson KD, Levine LD. Association between intrapartum antibiotic prophylaxis for group B Streptococcus colonization and clinical chorioamnionitis among patients undergoing induction of labor at term. Am J Obstet Gynecol 2023; 229 (06) 672.e1-672.e8
• 9 Venkatesh KK, Vladutiu CJ, Glover AV. et al. Is group B Streptococcus colonization associated with maternal peripartum infection in an era of routine prophylaxis?. Am J Perinatol 2021; 38 (S 01): e262-e268
• 10 Place K, Rahkonen L, Nupponen I, Kruit H. Vaginal Streptococcus B colonization is not associated with increased infectious morbidity in labor induction. Acta Obstet Gynecol Scand 2021; 100 (08) 1501-1510
• 11 Edwards JM, Watson N, Focht C. et al. Group B Streptococcus (GBS) colonization and disease among pregnant women: a historical cohort study. Infect Dis Obstet Gynecol 2019; 2019: 5430493
• 12 Schrag SJ, Zywicki S, Farley MM. et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342 (01) 15-20
• 13 Hussain FN, Al-Ibraheemi Z, Pan S. et al. The Accuracy of Group Beta Streptococcus rectovaginal cultures at 35 to 37 weeks of gestation in predicting colonization intrapartum. AJP Rep 2019; 9 (03) e302-e309
• 14 McCoy JA, Elovitz MA, Alby K, Koelper NC, Nissim I, Levine LD. Association of obesity with maternal and cord blood penicillin levels in women with group B Streptococcus colonization. Obstet Gynecol 2020; 136 (04) 756-764
• 15 El Helali N, Nguyen JC, Ly A, Giovangrandi Y, Trinquart L. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B Streptococcus screening. Clin Infect Dis 2009; 49 (03) 417-423
• 16 Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983; 148 (05) 802-809
• 17 Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, Dekker FW, Dörr PJ, Sprij AJ. Timing of group B Streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest 2010; 69 (03) 174-183
• 18 Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88 (05) 811-815
• 19 Prevention of Group B Streptococcal Early-Onset Disease in Newborns. ACOG Committee Opinion, Number 797. Obstet Gynecol 2020; 135 (02) 51-72
• 20 Scheftelowitz Cohen R, Chodik G, Eisenberg VH. Re-evaluating perinatal group B streptococcal screening in Israel—is it time for a change in policy?. Prev Med 2021; 153: 106716
• 21 Brigtsen AK, Jacobsen AF, Dedi L. et al. Group B Streptococcus colonization at delivery is associated with maternal peripartum infection. PLoS One 2022; 17 (04) e0264309
• 22 Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases NCfIaRD, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
• 23 Virranniemi M, Raudaskoski T, Haapsamo M. et al. The effect of screening-to-labor interval on the sensitivity of late-pregnancy culture in the prediction of group B Streptococcus colonization at labor: a prospective multicenter cohort study. Acta Obstet Gynecol Scand 2019; 98 (04) 494-499
• 24 Young BC, Dodge LE, Gupta M, Rhee JS, Hacker MR. Evaluation of a rapid, real-time intrapartum group B Streptococcus assay. Am J Obstet Gynecol 2011; 205 (04) 372.e1-372.e6
• 25 Tita ATN, Carlo WA, McClure EM. et al; A-PLUS Trial Group. Azithromycin to prevent sepsis or death in women planning a vaginal birth. N Engl J Med 2023; 388 (13) 1161-1170
• 26 Roca A, Camara B, Bognini JD. et al; PregnAnZI-2 Working Group. Effect of intrapartum azithromycin vs placebo on neonatal sepsis and death: a randomized clinical trial. JAMA 2023; 329 (09) 716-724